European Journal of Endocrinology (2003) ISSN

Similar documents
Age at menarche and adult height in girls born small for gestational age

Birth weight influences long-term catch-up growth and height prognosis of GH-deficient children treated before the age of 2 years

Dose Effects of Growth Hormone during Puberty

Growth hormone therapy in a girl with Turner syndrome showing a large increase over the initially predicted ht of 4 5

Adult height of prepubertal short children born small for gestational age treated with GH

Request for Prior Authorization Growth Hormone (Norditropin

4/23/2015. Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management. Conflict of Interest. Objectives THANK YOU!

Three-Year Growth Response to Growth Hormone Treatment in Very Young Children Born Small for Gestational Age Data from KIGS

and LHRH Analog Treatment in

PedsCases Podcast Scripts

Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None

Bone Development. V. Gilsanz and O. Ratib, Hand Bone Age, DOI / _2, Springer-Verlag Berlin Heidelberg 2012

Somatostatin Analog and Estrogen Treatment in a Tall Girl

The science behind igro

How to approach a child with growth concern

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

Zohreh Karamizadeh, MD; Anis Amirhakimi*, MD; Gholamhossein Amirhakimi, MD

PUBLICATIONS Abstracts and publications on the psychological data available.

Adult height in constitutionally tall stature:

Growth Hormones DRUG.00009

Growth and Puberty: A clinical approach. Dr Esko Wiltshire

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Critical Growth Phases for Adult Shortness

Correlation of Serum Follicular Stimulating Hormone

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka

Diagnosing Growth Disorders. PE Clayton School of Medical Sciences, Faculty of Biology, Medicine & Health

Feeding the Small for Gestational Age Infant. Feeding the Small for Gestational Age Infant

Pubertal Development in Japanese Boys

Growth Hormone Therapy

Endocrine Late Effects in Survivors of Pediatric SCT

X/00/$03.00/0 Vol. 85, No. 11 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society

Monitoring treatment in congenital adrenal

PedsCases Podcast Scripts

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Final Height in Short Children Born Small for Gestational Age Treated with Growth Hormone

Effect of letrozole on the predicted adult height in boys with constitutional delay of growth and puberty: A clinical trial.

Long-Term Experience with GnRH Agonist Treatment of Central Precocious Puberty

Endocrine: Precocious Puberty Health care guidelines for Spina Bifida

GROWTH HORMONE DEFICIENCY AND OTHER INDICATIONS FOR GROWTH HORMONE THERAPY CHILD AND ADOLESCENT

Follow-up Study of Adolescent Girls With a History of Premature Pubarche

General Approval Criteria for ALL Growth Hormone agents: (ALL criteria must be met)

Preface Acknowledgments Introduction Introductory Concepts Definitions and Context Chronological Age and Age Groups Why Study These Phenomena?

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents

OBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.

Precocious Puberty. Disclosures. No financial disclosures 2/28/2019

Running title: Growth hormone coverage for idiopathic short stature

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea

hypothyroidism Growth in early treated congenital ORIGINAL ARTICLES

Humatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Zomacton (aka. Tev-Tropin)

The neuroendocrine growth hormone clock and body mass. Are we programmed to grow to a certain size, to stop growing and to decay?

Dr. Nermine Salah El-Din Prof of Pediatrics

Wissenschaft. Edition. Edition Wissenschaft Forschungsgemeinschaft Funk e. V.. G Issue No. 22. October 2005

The New England Journal of Medicine EFFECT OF GROWTH HORMONE TREATMENT ON ADULT HEIGHT OF CHILDREN WITH IDIOPATHIC SHORT STATURE.

PFIZER INC. Study Centre: One centre from Hungary enrolled subjects in this study

A lthough it is assumed that growth hormone (GH) secretion

Genotropin, Norditropin, Nutropin, Nutropin AQ, Humatrope, Saizen,

Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only. Non-Preferred Growth Hormone Products

Aetna Better Health of Virginia

Growth Hormone plus Childhood Low- Dose Estrogen in Turner s Syndrome. N Engl J Med 2011;364: Present by R5 郭恬妮

A single sample GnRHa stimulation test in the diagnosis of precocious puberty

and premature puberty associated with lymphoblastic leukaemia

Reliability of an Objective Method of Evaluating Skeletal Maturity based on Cervical Vertebral Bone Age as Compared with the TW2 Method

Puberty and Pubertal Disorders Part 3: Delayed Puberty

Chronic renal failure and growth

International Society for Magnetic Resonance in Medicine (ISMRM), The 24th Annual Meeting and Exhibition, Singapore, 7-13 May 2016.

Radiological Estimation of Age from Hand Bone in Sudanese Infants and Toddlers

Proposed new target height equations for use in Australian growth clinics

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty

THE INFLUENCE OF ANDROGEN TREATMENT ON ULTIMATE HEIGHT IN MALES

2. Skeletal System. Aged Osteoporosis (post menopausal fractures - decreased bone density/ length) Loading Effects. Wednesday, 17 June 2015

Sex Steroid Treatment of Constitutionally Tall Stature*

The Effects of Gonadotropin Releasing Hormone Analogue Therapy on Girls with Gonadotropin-dependent Precocious Puberty

Evaluating the effects of asthma therapy on childhood growth: principles of study design

Crescimento Variantes do normal e patológico

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Circle Yes or No Y N. [If yes, skip to question 30.] 2. Is this request for a child? Y N. [If no, skip to question 20.]

GROWTH: A Clinical Perspective. Sharon E. Oberfield, M.D. Professor of Pediatrics Columbia University Medical Center February 12, 2007

GROWTH: A Clinical Perspective. Sharon E. Oberfield, M.D. Professor of Pediatrics Columbia University Medical Center February 12, 2007

Original article Central Eur J Paed 2018;14(1):68-72 DOI /p

Twenty-four Hour Plasma GH, FSH and LH Profiles in Patients with Turner's Syndrome

First Name. Specialty: Fax. First Name DOB: Duration:

Growth after renal transplants

Intrauterine Growth Retardation or Small Gestational Age. Series N.14

Judith Ross, 1 Peter A. Lee, 2 Robert Gut, 3 and John Germak Introduction

PHARMACY POLICY STATEMENT Indiana Medicaid

PHARMACY POLICY STATEMENT Indiana Medicaid

2. Is the request for Humatrope? Y N [If no, skip to question 6.]

TRANSITIONING FROM A PEDIATRIC TO AN ADULT ENDOCRINOLOGIST CARLOS A. LEYVA JORDÁN, M.D. PEDIATRIC ENDOCRINOLOGIST

GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK

Pituitary Disorders Pediatric Growth Hormone Deficiency

Transcription:

European Journal of Endocrinology (2003) 149 425 432 ISSN 0804-4643 CLINICAL STUDY Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA) Liora Lazar, Uri Pollak 1, Ofra Kalter-Leibovici 2, Athalia Pertzelan and Moshe Phillip Institute for Endocrinology and Diabetes, Schneider Children s Medical Center of Israel, Petah Tikva, 2 Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer and 1 Faculty of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel (Correspondence should be addressed to M Phillip; Email: mosheph@post.tau.ac.il) (L Lazar and U Pollak contributed equally to this work) Abstract Objective: Few data are available on the pubertal development of children born small for gestational age (SGA) who fail to show catch-up growth. Design: A longitudinal analysis compared the pubertal course of persistently short children born SGA compared to children with idiopathic short stature who were appropriate for gestational age (AGA). One hundred and twenty-eight short children (height SDS,21.7), including 76 (31 boys) born SGA and 52 (22 boys) born AGA, were regularly followed from early childhood to completion of puberty. Results: Puberty was attained at normal age (10.5 14 years in boys, 9.5 13 years in girls) for most children in both the SGA and AGA groups (boys, 80% and 77%; girls, 76% and 78% respectively). The duration of puberty was similar in the SGA and AGA groups. Menarche occurred at normal age range but was significantly earlier in the SGA girls (P, 0.01 by ANOVA). Despite the similar total pubertal growth, the patterns of growth differed significantly: SGA group accelerated growth and bone maturation rates from onset of puberty with peak height velocity at Tanner stages 2 3, followed by a decelerated growth rate and earlier fusion of the epiphyses; AGA group steady progression of bone elongation and maturation throughout puberty (pubertal growth, P, 0.05 in both sexes; bone maturation, P, 0.001 in both sexes). Final height in the SGA group was compromised compared with their target height (P, 0.001). Conclusion: Children born SGA have a normal pubertal course with a distinct pubertal growth pattern. This pattern may represent an altered regulation of their growth modalities. European Journal of Endocrinology 149 425 432 Introduction The adaptation of the fetus to conditions of undernutrition in utero involves an alteration in endocrine setpoints in the insulin, insulin-like growth factor (IGF) and growth hormone (GH) pathways. These are also maintained postnatally (1, 2) and may affect the long-term pattern of postnatal growth and development. A number of longitudinal studies have shown that although the majority of children born small for gestational age (SGA) exhibit significant catch-up growth during the first 6 12 months of life, about 10 17% do not. They tend to grow parallel to but below the normal centiles throughout childhood with no improvement during puberty, and they attain a final height (FHt) that is far below their genetic target height (THt) (3 6). The contribution of the pubertal process and the impact of pubertal growth on FHt in children born SGA remain unclear (4, 7 12), and the question of whether the in utero changes affect not only growth but also the pubertal process is still open. Most researchers report that puberty in these children is attained at a normal age or slightly earlier, and that their total pubertal growth and peak height velocity are normal. However, the bulk of these data were collected from cross-sectional studies that investigated the natural history of growth in children born SGA, but did not focus on the pubertal course. Furthermore, it is well established that subnormal growth during infancy or childhood has an impact on pubertal growth (13), yet the study samples included both children who exhibited catch-up growth with normalization of pre-pubertal height and children who remained short at 2 years of age and thereafter. Since 1975, the Institute for Endocrinology and Diabetes of what is now the Schneider Children s Medical Center of Israel has been following a large group of children born SGA who were referred because q 2003 Society of the European Journal of Endocrinology Online version via http://

426 L Lazar, U Pollak and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 of a failure to show sufficient catch-up growth. The aim of the present study was to characterize the data on the pubertal onset, course and growth of these children and to compare the findings with those of children with idiopathic familial short stature who were appropriate for gestational age (AGA) at birth. Subjects and methods Patients The study group included 128 short children drawn from a large population of short children referred to our endocrine clinic between the years 1975 and 1990. Seventy-six children (31 boys and 45 girls) were born SGA, defined as a birth weight below 22 S.D. for gestational age (14), and 52 (22 boys and 30 girls) had normal birth size for gestational age (15) (Table 1). Six children in the SGA group and four in the AGA group were born before term (gestational age 35 36 weeks), but their perinatal course was uneventful. There was no documentation of maternal disorders or abnormalities throughout pregnancy (specifically, heavy smoking, alcohol abuse or hypertension) in either the AGA or SGA group. Eight mothers (five in the SGA group and three in the AGA group) developed pre-eclampsia a few days prior to delivery. Selection for the study was based on the following criteria: inclusion available information on gestational age and weight at birth; persistent short stature (height SDS below 2 1.7 for chronological age) with no catch-up growth during infancy and childhood (chronological age 2.5 4 years); documented age and auxological data at onset of puberty; regular follow-up since childhood to completion of puberty; exclusion presence of endocrinological or chronic diseases such as chronic renal failure, severe bronchial asthma with regular steroid treatment, inflammatory bowel disease and celiac disease; neurological handicap; previous or ongoing chemotherapy; chromosomal aberrations; malformation syndromes including dysmorphic features characteristic of Russel Silver syndrome; and skeletal dysplasia. Although receipt of treatment interfering with growth and puberty was not one of the exclusion criteria, it was not relevant, as none of the children developed precocious puberty, and early puberty is not an indication for treatment. Furthermore, the children in whom puberty was delayed had already been progressing spontaneously to puberty at the ages when sex steroids would be indicated for induction of puberty (boys. 15 years; girls. 13 years). Therefore, no growth-related treatment was presented for any of the patients. Stringent conditions were applied so that a longitudinal analysis of the pubertal course could be conducted in a relatively large sample despite the retrospective design of the study. The final cohort was representative of the two groups (SGA and AGA), as the dropouts differed from the participants only in lack of continuous follow-up. Methods Birth and perinatal data were taken from the medical records. Birth weight SDS for gestational age was calculated according to the tables of Usher and McLean (15). During the pre-pubertal period, height, weight and pubertal stage were determined at 4 12-month intervals. During puberty, all the children were followed every 3 4 months. For purposes of comparison of both sexes at different ages, body mass index (BMI) (weight in kilograms/height in m 2 ) was calculated and height and BMI values were converted into SDS using the updated American CDC reference values (16). Pubertal stage was assessed at every visit according to the method of Marshall and Tanner (17, 18). At each pubertal stage, the advancement of pubarche (degree of sexual hair) and gonadarche (testicular volume in boys and stage of breast development in girls) was classified separately. Onset of puberty was categorized by the age at which pubertal signs (gonadarche with or without pubarche) appeared, as follows: precocious puberty before age 8 years in girls and 9 years in boys (19, 20); early puberty ages 8 9.5 years in girls and 9 10.5 years in boys (the maximum cut-off ages in girls and boys correspond to 22 S.D. below the average age of pubertal onset) (20); average puberty ages 9.5 13 years in girls and 10.5 14 Table 1 Pertinent birth data of 128 short children, 76 born SGA and 52 born AGA. SGA AGA Term Pre-term Term Pre-term Number Total 70 6 48 4 Boys 28 3 20 2 Girls 42 3 28 2 Gestational age (weeks) (mean^sd) 39.2^1.3 36.0^0.7 39.8^0.5 35.6^0.8 Birth weight (g) (mean^sd) 2007^190 1640^175 3270^349 2381^225 Birth weight SDS* 22.04^0.78 21.98^0.6 1.06^0.9 0.97^0.7 * Birth weight SDS was calculated according to the tables of Usher and McLean (15).

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 years in boys; delayed puberty beyond the age of 13 years in girls and 14 years in boys (19 21). Precocious pubarche was defined as the appearance of sexual hair only before age 8 years in girls and 9 years in boys (19, 20). Pubertal rate was estimated by the duration of transition from Tanner stages 2 to 5. A duration of less than 2.5 years was considered fast puberty and of more than 4 years, slow puberty (19, 20). Total pubertal growth was calculated as the difference between height at completion and onset of puberty. We applied this criterion to the whole cohort for purposes of consistency, as all the children were followed until completion of puberty, and all the girls but only some of the boys were followed to FHt. The peak height velocity (maximal growth rate during puberty) was analyzed as the highest growth rate (measured every 3 months throughout puberty) over a complete 1-year period and was related to the pubertal stage at its occurrence. Bone age (BA) was estimated according to the Atlas of Greulich and Pyle (22) every 1 2 years throughout the pre-pubertal period, and during puberty when clinical evaluation revealed a transition of the pubertal stage. FHt was determined when growth velocity dropped to less than 2.0 cm/year and BA was beyond 15 years in girls and 17 years in boys. Predicted final height (PFHt) was calculated by the method of Bayley and Pinneau (23) using the average tables for both boys and girls. THt, the corrected mid-parental height, was calculated according to Tanner et al. (24). Analysis of all the available auxological characteristics (height, BMI and BA) was performed in all children at early childhood (last measurement between ages 2.5 and 4 years), at onset of puberty, at each pubertal stage (defined by gonadarche), and at FHt. Longitudinal analysis of growth and bone maturation rates was carried out throughout puberty. All clinical and radiological evaluations were performed by the same team, comprising pediatric endocrinologists and nurses. Tanner staging was performed by Puberty in children with intrauterine growth retardation 427 the same three senior pediatric endocrinologists, among whom interpreter consistency was validated. The data on basal and stimulated levels of gonadotropins, adrenal androgens and sex hormones were not analyzed because the blood tests were not performed consistently at regular periods throughout puberty. However, the hormone levels of those children who did undergo blood testing were within the normal range for the various pubertal stages. It is of note that the decision regarding hormonal testing was made by the medical consultant on an individual basis in children with either early or delayed puberty. These tests were not contributory and did not effect a change in diagnosis. Hence, they did not constitute a bias in the cohort selection. Statistical analysis The BMDP program (25) was used for the statistical analyses. Values are expressed as means^s.d. Comparisons between groups were carried out using ANOVA and ANOVA with repeated measures to test for changes over time. Stepwise multiple regression analysis was applied to evaluate the effect of various early pre-pubertal parameters (birth weight, height, BMI and BA) on age at onset of puberty and on pubertal growth spurt. Results The clinical characteristics of the SGA and AGA groups at birth are shown in Table 1, and in early childhood in Table 2. The chronological age (CA), the BA delay over CA (CA minus BA), and the BMI SDS in early childhood were remarkably similar in the two groups. The height SDS (Ht SDS) of both groups was approximately 2 1.8 to 21.7 throughout early childhood. Age at onset of puberty was significantly lower in the children born SGA than in the children born AGA Table 2 Early childhood and early pubertal auxological data of 128 short children, 76 born SGA (31 boys and 45 girls) and 52 born AGA (22 boys and 30 girls). Values are means^s.d. Early childhood Onset of puberty SGA AGA P value* SGA AGA P value* Boys CA (years) 3.4^0.6 3.7^0.4 NS 12.0^0.9 13.0^1.1, 0.01 CA 2 BA (years) 2.6^1.0 2.7^0.9 NS 1.9^0.9 2.6^1.1, 0.001 Ht SDS 21.8^0.4 21.7^0.2 NS 21.6^0.6 21.7^0.3, 0.01 BMI SDS 20.4^0.2 20.3^0.5 NS 20.5^0.8 20.6^0.7 0.05 Girls CA (years) 3.6^0.8 3.3^0.6 NS 10.4^1.5 11.4^1.3, 0.01 CA 2 BA (years) 1.9^0.7 2.0^1.0 NS 0.4^1.1 1.8^0.9, 0.001 Ht SDS 21.8^0.4 21.8^0.5 NS 21.65^0.4 21.8^0.5, 0.01 BMI SDS 20.4^0.8 20.4^0.5 NS 20.5^0.9 20.7^0.6 0.05 NS ¼ not significant. * Significance of difference between SGA and AGA, for each parameter.

428 L Lazar, U Pollak and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 (P, 0.01 for both sexes). However, comparison of the age distribution histograms (Fig. 1) revealed that although the SGA group had a higher prevalence of early puberty than the AGA group (for boys, 13% vs 5%; for girls, 20% vs 3%), and a lower prevalence of delayed puberty (for boys, 7% vs 18%; for girls 4% vs 19%), most of the boys and girls of both groups attained puberty at a normal age (for boys, 80% of the SGA group vs 77% of the AGA group; for girls, 76% vs 78% respectively). None of the children, either SGA or AGA, developed precocious puberty. Figure 1 Distribution of age at onset of puberty in 76 short children born SGA (31 boys, 45 girls) compared with 52 short children born AGA (22 boys, 30 girls). Multiple regression analysis showed that the only pre-pubertal predictor of age at onset of puberty was birth weight SDS. However, only a small percentage of the variance was explained by this parameter (r ¼ 0.27). No correlation was found between age at onset of puberty and any of the other pre-pubertal variables: gestational age, height, BMI, and BA delay over CA. Analysis of the auxological data at onset of puberty (Table 2) showed that the BA of the boys and girls in the SGA group was significantly more advanced than that of the AGA children (P, 0.001 for boys and girls). Their Ht SDS and BMI SDS were also higher (P, 0.01 and P ¼ 0.05 respectively for both boys and girls). Menarche occurred within the normal age range in both groups, but significantly earlier in the SGA than the AGA group (P, 0.01) (Table 3). Longitudinal analysis of the pubertal course (Table 3) yielded a similar mean duration of puberty in the two groups. Mean total pubertal growth and the peak height velocity were also similar. On stepwise regression analysis using total pubertal growth as an independent variable and age at onset of puberty and group (SGA or AGA) as dependent variables, total pubertal growth was negatively correlated with age at onset of puberty in both boys and girls (r 2 ¼ 0.42 and 0.41 respectively). However, being in the SGA or the AGA group did not correlate with total pubertal growth, either in the boys or in the girls. Yet, the pattern of pubertal growth (analyzed using ANOVA with repeated measurements) was significantly different between the SGA and the AGA groups (Fig. 2). In both boys and girls, there was a significant statistical interaction between the SGA and the AGA groups for height gain (P, 0.05) (Fig. 2A and B) and absolute height changes (P, 0.05) (Fig. 2C and D). The SGA group reached peak height velocity at an earlier pubertal stage (Tanner stage 3 for boys and stage 2 for girls) than the AGA group (Tanner stages 4 5 and 3 4 respectively). This early acceleration was followed by a deceleration toward completion of puberty, with Ht SDS dropping back to 21.6 SDS. In the AGA group, the height gain of the boys improved continuously to Table 3 Pubertal course in 128 short children, 76 born SGA and 52 born AGA. Values are means^s.d. Boys Girls SGA AGA P value* SGA AGA P value* Number 31 22 45 30 Duration P2 P5 (years) 3.9^0.7 3.9^1.2 NS 2.9^1.2 2.9^0.9 NS TPG (cm) 26.1^3.6 24.1^4.6 NS 18.1^3.4 17.3^3.3 NS PHV (cm) 9.6^2.7 8.3^2.8 NS 7.6^2.0 7.3^1.9 NS (At pubertal stage) 3 4 5 2 3 4 Menarche ages (years) 12.6^1.6 13.0^1.4,0.01 Duration P2 P5 ¼ duration of puberty from Tanner stage 2 to 5; TPG ¼ total pubertal; growth; PHV ¼ peak height velocity. * Significance of difference between SGA and AGA, for each parameter.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 Puberty in children with intrauterine growth retardation 429 Figure 2 Growth and bone maturation rates in 76 short children born SGA (31 boys, 45 girls) compared with 52 short children born AGA (22 boys, 30 girls) followed longitudinally throughout puberty. P1 early childhood; P2, P3, P4 and P5 pubertal stages according to Tanner.

430 L Lazar, U Pollak and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 completion of puberty, and the height gain of the girls was steady at each pubertal stage (Fig. 2A and B). Therefore, by completion of puberty, the significant earlier difference in Ht SDS between the groups disappeared (Fig. 2C and D). The rate of bone maturation from Tanner stages 2 to 5 also demonstrated a highly significant different interaction over time between the two groups (for both boys and girls, P, 0.001) (Fig. 2E and F). In the boys, BA was delayed in childhood and at onset of puberty. Thereafter, in the SGA boys, bone maturation accelerated, leading to a significant decrease in BA delay over CA, starting already in Tanner stages 2 and 3, whereas in the boys born AGA, advancement of BA was observed only towards Tanner stage 4. In the girls born SGA, BA was already more advanced and corresponded to CA at onset of puberty. Thereafter, BA advanced steadily over time. In the girls born AGA, delayed BA was observed in the early stages of puberty, and advancement occurred only towards Tanner stages 4 and 5. All 75 girls, but only 15 boys (SGA, 8; AGA, 7), were followed to FHt. The remaining boys were followed to completion of puberty. We considered their PFHt at Tanner stage 5 as their FHt, since by that time, their BA was 15.5 16 years, at which point the PFHt is accurate in both boys with a normal growth pattern as well as short boys, either SGA or AGA, with early or delayed puberty (23, 26). The FHt of the children in the two groups was not significantly different (Table 4). After adjusting for THt, we noted a significant deficit in FHt in the SGA group (for boys, P, 0.01; for girls, P, 0.001), but not in the AGA group were FHt and THt were similar. THt was significantly greater in the SGA than the AGA group (for boys, P, 0.01; for girls, P, 0.001). Discussion This is, to the best of our knowledge, one of the first longitudinal studies providing information on the pattern of pubertal development and pubertal growth of persistently short children born SGA. The major finding of the study was that the pattern of growth in short children born SGA is distinct from that in children born AGA, with peak height velocity occurring at an earlier pubertal stage despite the similar total pubertal growth of the two groups. There are several limitations to this study. We selected only those patients who were followed over the long term. Therefore, this cohort is not representative of the whole SGA and AGA population. Nevertheless, this is a relatively large uniform sample with clear differences between the SGA and AGA groups. Secondly, as the data were collected retrospectively, not all the boys were followed to FHt. However, as all completed puberty (Tanner stage 5) we were able to use their PFHt, which is accurate at bone age 15.5 16, as their FHt (23, 26). The mean age at onset of puberty was within the normal range in the SGA group (boys, 12.0^0.9; girls, 10.4^1.5), albeit significantly lower than in the AGA group (P, 0.01). Although one study reported delayed pubertal onset in children born SGA compared with controls (27), all other researchers had similar findings to ours. They attributed this difference to the relatively early puberty in all children born SGA compared with the delayed puberty in most short children born AGA (7 9, 11). However, our data demonstrated a normal pubertal onset in the vast majority of children born SGA (80% of the boys, 76% of the girls), similar to the short children born AGA (77% of the boys, 78% of the girls). Only 13% of the boys and 20% of the girls born SGA had a relatively early puberty (onset at age 9 10.5 and 8 9.5 years respectively), while 18% of the boys and 19% of the girls born AGA had delayed puberty (onset of puberty beyond ages 14 and 13 years respectively). This small subset of patients might explain the statistically significant difference in mean age at onset of puberty between the whole SGA and AGA groups (P, 0.01 for both boys and girls) (Fig. 1, Table 2). Some studies have suggested that children born SGA might be exposed to higher insulin levels due to the presence of insulin resistance beginning in the prenatal period. High insulin levels could, later in life, stimulate early secretion of luteinizing hormone, leading to early puberty (2, 28, 29). Nevertheless, in most of the Table 4 FHt compared with THt in 128 short children, 76 born SGA and 52 born AGA. Values are means^s.d. Boys Girls SGA AGA P value* SGA AGA P value* Number 31 22 45 30 FHt (cm) 169.5^5.1 168.3^4.0 NS 153.6^5.7 152.8^3.8 NS THt (cm) 173.9^5.2 167.5^3.6, 0.001 162.9^5.2 153.7^5.6, 0.001 P value*, 0.01 NS, 0.001 NS NS ¼ not significant. * Significance of difference between SGA and AGA, for each parameter. Actual FHt, n ¼ 8; predicted FHt at completion of puberty, n ¼ 23. Actual FHt, n ¼ 7; predicted FHt at completion of puberty, n ¼ 15.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 children born SGA in our sample, the course and timing of puberty were within the normal range. This finding may place doubt on the role of the uterine environment on hormone secretion at puberty (19, 30). Despite the comparable rate of development of gonadarche in the children of both groups, in the girls born SGA, menarche, though occurring at an adequate age, was significantly earlier than in the girls born AGA (P, 0.01). This finding is in agreement with the study of Ibanez et al. (31). The similar total pubertal growth and peak height velocity magnitude in the short SGA and AGA children implies an appropriate pubertal growth spurt in children born SGA. This finding is in agreement with the study of Leger et al. (9), who claimed that puberty has no influence on final height outcome in these children, as their pubertal spurt is adequate. Nevertheless, the FHt of the SGA group was compromised (Table 4). One possible explanation for this finding may be a smaller than expected growth spurt. There is a well-known negative relationship between total pubertal growth and age of pubertal onset (30). Since the mean age at onset of puberty in our SGA group was 1 year earlier than in the AGA group, their growth spurt should have been larger. Indeed, we found that age at pubertal onset was negatively associated with pubertal growth spurt in children of both groups. However, no correlation was demonstrated between the pubertal growth spurt and belonging to either the SGA or the AGA group. This discrepancy may also be related to the similar age at onset of puberty in the majority of children born either SGA or AGA. Another possible explanation for this finding may lie in the pattern of their pubertal growth. In contrast to a previous report (12), all the children born SGA in our series demonstrated growth acceleration from onset of puberty, with early peak height velocity at Tanner stage 3 in boys and Tanner stage 2 in girls (Fig. 2), compared with Tanner stages 4 5 in boys and 3 4 in girls of the AGA group, and in children with normal puberty (19, 20). The early growth acceleration yielded an improvement in Ht SDS, which proved to be transient, as growth deceleration occurred from mid-puberty to FHt, with a drop back to the previous height percentiles (Fig. 2). Other authors have also suggested that children born SGA show less pubertal growth than expected, being that their peak height velocity, though occurring earlier than in children with AGA, is not more pronounced (11). The accelerated bone elongation was accompanied by an accelerated bone maturation rate and early fusion of the growth plates (Fig. 2E and F). These findings are in accordance with previous reports on bone maturation of children born SGA (7, 8, 11). By contrast, the short children born AGA exhibited gradual growth acceleration and bone maturation rates throughout puberty, with an appropriate progression of BA. Puberty in children with intrauterine growth retardation 431 The pathophysiologic mechanism underlying the unique pubertal growth pattern of children born SGA remains unclear. It is well established that the regulation of the insulin, GH and IGF-I pathways and the sensitivity of their receptors are altered by the abnormal prenatal environment of children born SGA (1, 2, 32 34). Perhaps the sex hormone receptors in the growth plate are altered as well. This would result in a different response to normal hormonal stimulations and lead to unusual pubertal growth. Conclusions Children born SGA with persistent short stature demonstrate a similar timing and course of pubertal development to normal children, and to short children born AGA. This finding may imply an intact hypothalamic pituitary gonadal axis. However, their FHt is compromised, perhaps due to their distinct pattern of pubertal growth, characterized by an early acceleration followed by a relatively early deceleration in association with early fusion of the epiphyses, which may result from altered regulation of growth modalities. Acknowledgements We would like to thank Pnina Lilos for performing the statistical analysis and Gloria Ginzach and Melanie Kawe for their editorial and secretarial assistance. This work is part of Mr Pollak s MD thesis. References 1 Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA et al. Insulin resistance in short children with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 1997 82 402 406. 2 Gluckman PD, Cutfield W, Harding JE, Milner D, Jensen E, Woodhall S et al. Metabolic consequences of intrauterine growth retardation. Acta Paediatrica 1996 417 (Suppl) 3 6. 3 Fitzhardinge PM & Inwood S. Long-term growth in small-for-dates children. Acta Paediatrica Scandinavica 1989 349 27 33. 4 Albertsson-Wikland K & Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatrica Scandinavica 1994 399 (Suppl) 64 70. 5 Karlberg J & Albertsson-Wikland K. Growth in full term small for gestational age infants from birth to final height. Pediatric Research 1995 38 733 739. 6 Karlberg J & Lou ZC. Foetal size to final height. Acta Paediatrica 2000 89 632 636. 7 Job JC & Rolland A. Histoire naturelle des retards de croissance a debut intra-uterin. Croissance pubertaireet taille adulte. Archives françaises de pédiatrie 1986 43 301 306. 8 Chaussain JL, Colle M & Ducret JP. Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatrica Scandinavica 1994 399 72 73. 9 Leger J, Limoni C, Collin D & Czernichow P. Prediction factors in the determination of final height in subjects born small for gestational age. Pediatric Research 1998 43 808 812. 10 Arisaka O, Arisaka M, Kiyokawa N, Shimizu T, Nakayama Y & Yabuta K. Intrauterine growth retardation and early adolescent growth spurt in two sisters. Clinical Pediatrics 1986 25 559 561.

432 L Lazar, U Pollak and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003) 149 11 Preece MA. Puberty in children with intrauterine growth retardation. Hormone Research 1997 48 (Suppl 1) 30 32. 12 Vincens-Calvet E, Espadero RM & Carrascosa A. Longitudinal study of the pubertal growth spurt in children born small for gestational age without postnatal catch-up growth. Journal of Pediatric Endocrinology and Metabolism 2002 15 381 388. 13 Lou ZC & Karlberg J. Critical growth phases for adult shortness. American Journal of Epidemiology 2000 15 125 131. 14 Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987 65 663 737. 15 Usher R & McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements of infants born between 25 and 44 weeks of gestation. Pediatrics 1969 74 901 910. 16 Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS & Wei R. CDC growth charts: United States. Advance Data 2000 314 1 27. 17 Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291 303. 18 Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood 1970 45 13 23. 19 Grumbach MM & Styne DM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In Williams Textbook of Endocrinology, edn 9, pp 1509 1625. Eds JD Wilson & DW Forester. Philadelphia, PA: WB Saunders, 1998. 20 Bridges NA & Brook CGD. Disorders of puberty. In Clinical Paediatric Endocrinology, edn 3, pp 253 273. Ed. CGD Brook. Oxford: Blackwell, 1995. 21 Wheeler MD. Physical changes of puberty. Endocrinology and Metabolism Clinics of North America 1991 29 1 14. 22 Greulich WW & Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, edn 2, Stanford, CA: Stanford University Press, 1959. 23 Bayley N & Pinneau S. Tables for predicting adult height from skeletal age. Revised for use with the Greulich Pyle hand standards. Journal of Pediatrics 1952 40 423 441. 24 Tanner JM, Goldstein H & Whitehouse RH. Standards for children s height at age 2 9 years allowing for height of parents. Archives of Disease in Childhood 1970 45 755 762. 25 Dixon WJ, ed. BMDP Statistical Software, Los Angeles, CA: University of California Press, 1992. 26 Zachmann M, Sobradillo B, Frank M, Frisch H & Prader A. Bayley Pinneau, Roche Wainer Thissen and Tanner height predictions in normal children and in patients with various pathological conditions. Journal of Pediatrics 1978 93 749 755. 27 Lienhardt A, Carel JC, Preux PM, Coutant R & Chaussain JL. Amplitude of pubertal growth in short stature children with intrauterine growth retardation. Hormone Research 2002 57 (Suppl 2) 88 94. 28 Cara JF & Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal interstitial cells. Endocrinology 1988 123 435 452. 29 Chiarelli F, di Ricco L, Mohn A, De Martino M & Verrotti A. Insulin resistance in short children with intrauterine growth retardation. Acta Paediatrica 1999 428 (Suppl) 62 65. 30 Palmert MR & Boepple PA. Variations in the timing of puberty: clinical spectrum and genetic investigation. Journal of Clinical Endocrinology and Metabolism 2001 86 2364 2368. 31 Ibanez L, Ferrer A, Marcos MV, Rodriguez-Hierro F & de Zegher F. Early puberty: rapid progression and reduced final height in girls with low birth weight. Pediatrics 2000 106 U73 U75. 32 De Waal WJ, Hokken-Koelega ACS, Stijnen TH, de Muinck Keizer- Scharma SM & Drop SL. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. Clinical Endocrinology 1994 41 621 630. 33 Boguszewski M, Rosenberg S & Albersson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. Journal of Clinical Endocrinology and Metabolism 1995 80 2599 2606. 34 Ducos B, Cabrol S, Houang M, Perin L, Hozenberger M & Le Bouc Y. IGF type 1 receptor ligand binding characteristics are altered in a subgroup of children with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 2001 86 5516 5524. Received 23 January 2003 Accepted 28 July 2003